<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mammalian cyclin-dependent kinase inhibitors fall into two families, the INK4 and the CIP/KIP </plain></SENT>
<SENT sid="1" pm="."><plain>The CIP/KIP family comprises three structurally related members, including p21CiP1/WAF1, p27KIP1, and p57KIP2 </plain></SENT>
<SENT sid="2" pm="."><plain>These proteins are <z:hpo ids='HP_0000001'>all</z:hpo> capable of inhibiting the progression of the cell cycle by binding and inhibiting G(1) cyclin/cyclin-dependent kinase complexes </plain></SENT>
<SENT sid="3" pm="."><plain>In humans, p57KIP2 is expressed specifically in skeletal muscle, heart, brain, kidney, and lung </plain></SENT>
<SENT sid="4" pm="."><plain>Human KIP2 resides in 11p15.5, a chromosomal region that is a common site for loss of heterozygosity in certain <z:hpo ids='HP_0100242'>sarcomas</z:hpo>, <z:e sem="disease" ids="C0027708" disease_type="Neoplastic Process" abbrv="">Wilms' tumors</z:e>, and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> associated with the <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Because of the function, selective expression, and chromosomal location of p57KIP2, we undertook the present study to search for potential mutations of KIP2 in a cohort of 126 tumors composed of 75 soft tissue <z:hpo ids='HP_0100242'>sarcomas</z:hpo> and 51 Wilms' <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The KIP2 gene was characterized by Southern blot, comparative multiplex PCR, PCR -single-strand conformational polymorphism, and DNA sequencing assays in these <z:hpo ids='HP_0002664'>neoplasms</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Deletions of the KIP2 gene or point mutations at the region encoding the cyclin-dependent kinase inhibitory domain were not found in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>The absence of KIP2 mutations might indicate that these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> arise due to defects at a closely linked but separate locus </plain></SENT>
<SENT sid="9" pm="."><plain>Alternatively, similarly to the mouse homologue, inactivation of KIP2 could occur via <z:mp ids='MP_0003121'>genomic imprinting</z:mp> </plain></SENT>
</text></document>